|
Terminated
|
NCT01211639 -
Genetic Evaluation of Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy
|
N/A |
|
Completed
|
NCT02004444 -
JC Virus Reactivation in Multiple Sclerosis
|
N/A |
|
Recruiting
|
NCT05849467 -
Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy
|
Phase 1 |
|
Recruiting
|
NCT01730131 -
Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
|
|
|
Recruiting
|
NCT04781309 -
NT-I7, a Long-Acting Recombinant IL-7 Molecule, as an Immune Reconstitution Strategy for Lymphopenia in Patients With Progressive Multifocal Leukoencephalopathy
|
Early Phase 1 |
|
Completed
|
NCT02694783 -
Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy With Ex Vivo Generated Polyomavirus-Specific T-Cells
|
Early Phase 1 |
|
Completed
|
NCT01132053 -
Role of Inflammation in Progressive Multifocal Leukoencephalopathy (PML)
|
|
|
Completed
|
NCT03399981 -
Tysabri Observational Cohort Study - Multiple Sclerosis (MS) Registries
|
|
|
Terminated
|
NCT00746941 -
Study to Explore the Effect of Mefloquine in Participants With Progressive Multifocal Leukoencephalopathy (PML)
|
Phase 1/Phase 2 |
|
Completed
|
NCT02895581 -
Retrospective Study of the Survival of Patients Suffering From Hiv-related Progressive Multifocal Leukoencephalopathy
|
N/A |
|
Recruiting
|
NCT04453917 -
Dynamics of T Cell Expression of Immune Checkpoint Molecules in Progressive Multifocal Leukoencephalopathy
|
N/A |
|
Recruiting
|
NCT04091932 -
Treatment of PD-1 Inhibitor in AIDS-associated PML
|
Phase 2 |
|
Not yet recruiting
|
NCT06276504 -
Pembrolizumab in Progressive Multifocal Leukoencephalopathy (PML) in Immunocompromised Patients Without HIV Infection
|
Phase 2/Phase 3 |